Krónikus vesebetegség: vizsgálatok itt: Dél-Korea

In Dél-Korea 26 Also abroad 798

26 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

No phaseTaking people
Observational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in Progressive Chronic Kidney Disease Patients.
Where
Seoul
Életkor
19 év and over
People
3125
Run by
HK inno.N Corporation
See details and how to joinNCT07930169
3. fázisTaking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Ansan-si, Anyang-si, Busan, Cheonan-si, Goyang-si, Gwangju, Seongnam-si, Seoul, Wŏnju, Yangsan
Életkor
18 év and over
People
5000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
3. fázisTaking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Busan, Daegu, Guri-si, Gwangju, Namdong-gu, Seongnam, Seoul, Ulsan
Életkor
50 év and over
People
7140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
1/2. fázisTaking people
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Where
Seoul
Életkor
18 év to 75 év
People
94 worldwide
Run by
Ingenia Therapeutics INC
See details and how to joinNCT07231679
3. fázisTaking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
Bundang Gu, Busan, Cheongju-si, Seoul, Taegu
Életkor
18 év to 100 év
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
3. fázisTaking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Daegu, Seongnam-si, Seoul, Yangsan
Életkor
1 év to 18 év
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
3. fázisTaking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Anyang, Cheonan-si, Seoul, Wŏnju, Yangsan
Életkor
18 év to 99 év
People
2800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
2/3. fázisTaking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Anyang-si, Daegu, Gangnam-gu, Goyang-si, Guri-si, Gwangju, Ilsan-gu, Seoul, Wŏnju
Életkor
18 év and over
People
3110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
3. fázisTaking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Anyang-si, Busan, Cheonan-si, Daejeon, Goyang-si, Guri-si, Junggu, Seoul
Életkor
18 év and over
People
7000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
No phaseTaking people
Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule
Where
Jeonju
Életkor
19 év and over
People
172
Run by
LG Chem
See details and how to joinNCT06206135
No phaseCsak meghívásos
Cuffless BP Monitoring in Hemodialysis
Where
Seoul
Életkor
19 év and over
People
240
Run by
Gangnam Severance Hospital
See details and how to joinNCT07753876
No phaseTaking people
Self-Management Data and Disease Progression in Chronic Kidney Disease
Where
Daejeon
Életkor
19 év to 84 év
People
300
Run by
Chungnam National University Hospital
See details and how to joinNCT07754097
No phaseCsak meghívásos
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
Where
Seoul
Életkor
19 év and over
People
800 000
Run by
Novo Nordisk A/S
See details and how to joinNCT07673822
No phaseTaking people
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
Where
Seoul
Életkor
19 év to 85 év
People
1952
Run by
Yonsei University
See details and how to joinNCT07524101
3. fázisTaking people
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Where
Ansan, Incheon, Seoul
Életkor
18 év and over
People
429 worldwide
Run by
Genexine, Inc.
See details and how to joinNCT06466785
2. fázisTaking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Busan, Goyang-si, Gyeonggi-do, Seoul
Életkor
18 év and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
3. fázisTaking people
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Where
Seoul, Yangsan-si, Gyeongsangnam-do
Életkor
0 év to 18 év
People
56 worldwide
Run by
Amgen
See details and how to joinNCT03633708
No phaseTaking people
Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)
Where
Seoul
Életkor
19 év to 84 év
People
900
Run by
Yonsei University
See details and how to joinNCT04708587
No phaseTaking people
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD
Where
Seongnam-si
Életkor
19 év and over
People
18
Run by
Bundang CHA Hospital
See details and how to joinNCT06982573
2. fázisTaking people
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
Where
Ansan-si, Busan, Cheonan, Daegu, Goyang-si, Guri-si, Gwangmyeong, Incheon, Jeonju, Seongnam-si, Seoul, Uijeongbu-si, Wŏnju, Yangsan
Életkor
19 év and over
People
186
Run by
Aptabio Therapeutics, Inc.
See details and how to joinNCT06962098
No phaseCsak meghívásos
QOL and Mental Health Using APD With Remote Monitoring System
Where
Wŏnju
Életkor
18 év and over
People
50
Run by
Wonju Severance Christian Hospital
See details and how to joinNCT07012499
No phaseTaking people
Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease
Where
Seoul
Életkor
19 év and over
People
642
Run by
Yonsei University
See details and how to joinNCT06322056
No phaseTaking people
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
Where
Goyang-si
Életkor
19 év and over
People
1000
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06126016
3. fázisNot yet taking people in Dél-Korea
Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients
Where
Ansan
Életkor
19 év and over
People
348
Run by
Daewoong Pharmaceutical Co. LTD.
See details and how to joinNCT06606093
No phaseTaking people
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Where
Seoul
Életkor
2 év and over
People
6000
Run by
LG Chem
See details and how to joinNCT01604395